# Micro-helix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/micro-helix

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.micro-helix.com
- Latest round: Series A (Aug 15, 2016)
- Investors on record: 5

## About

Established in 2014 and based in Beijing, China, Micro-helix operates a medical and health services company that provides genetic testing services for hereditary medication. In June 2015, the company raised angel funding from new investors TCL Capital and ASB Venture (China) Holdings. In August 2016, it completed a series A funding from new investors Cast Pot Net, Elite Capital, and Golden Sunflower Capital.

Micro-helix focuses on providing services such as hereditary cardiovascular disease, drug genetic testing, NIPT testing, bone tumor and drug genetic testing, genomics research, transcriptomics research and other services. Products include genetic workstations, genetic operating systems, genetic databases, and genetic big data cloud platform services, as well as genetic training courses and other services.

## Funding rounds

- Series A, Aug 15, 2016 — Golden Sunflower Capital, Elite Capital, Cast pot net
- Angel, Jun 18, 2015 — ASB Ventures, TCL Capital

## Investors

- ASB Ventures (https://capitalatlas.ai/funds/asb-ventures) — Angel
- TCL Capital (https://capitalatlas.ai/funds/tcl-capital) — Angel
- Golden Sunflower Capital (https://capitalatlas.ai/funds/golden-sunflower-capital) — Series A
- Elite Capital (https://capitalatlas.ai/funds/elite-capital) — Series A
- Cast pot net — Series A